KMPHARMACEUTICAL's Largest Shareholder Kang Il-mo Maintains 39.32% Stake After 5-to-1 Reverse Stock Split, Extends Pledge Loans
The number of shares held by largest shareholder Kang Il-mo and special related parties decreased from 10,965,754 to 2,193,150 due to a 5-to-1 reverse stock split, but the ownership ratio remains unchanged at 39.32%.
Following the stock split, the total number of voting shares outstanding changed from 27,887,050 to 5,577,410.
Existing share pledge agreements with IBK Investment & Securities and Industrial Bank of Korea have been extended to July 7, 2026 and December 4, 2026 respectively, with total pledged shares of 1,197,489 representing 21.47% of outstanding shares.
This event involves a stock split with no new issuance, thus no dilution for existing shareholders.
[AI Summary]The largest shareholder's stake remains unchanged with only a stock split adjustment, posing no dilution concern for minority investors, but the extension of collateralized loans indicates ongoing financial leverage for the controlling shareholder, which may be an investment risk.